TB Alternative Assets Ltd. Purchases 7,866 Shares of Docusign Inc. $DOCU

Posted by Brenda Bartman on Oct 16th, 2026

TB Alternative Assets Ltd. purchased a new stake in Docusign Inc. (NASDAQ:DOCU – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 7,866 shares of the company’s stock, valued at approximately $528,000. Docusign comprises 0.1% of TB Alternative Assets Ltd.’s portfolio, making the stock its 29th largest holding.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DOCU. V Square Quantitative Management LLC bought a new stake in Docusign during the 3rd quarter worth about $27,000. WealthCollab LLC grew its holdings in Docusign by 372.4% during the 1st quarter. WealthCollab LLC now owns 855 shares of the company’s stock worth $41,000 after acquiring an additional 674 shares during the period. Elevation Wealth Partners LLC grew its holdings in Docusign by 71.1% during the 3rd quarter. Elevation Wealth Partners LLC now owns 876 shares of the company’s stock worth $59,000 after acquiring an additional 364 shares during the period. Virtus Advisers LLC acquired a new stake in Docusign during the 2nd quarter worth $47,000. Finally, Rakuten Securities Inc. bought a new stake in shares of Docusign during the 2nd quarter valued at $49,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider James Shaughnessy sold 12,000 shares of the firm’s stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $68.80, for a total transaction of $825,600.00. Following the sale, the insider owned 50,591 shares of the company’s stock, valued at $3,480,660.80. This trade represents a 19.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Allan Thygesen sold 26,250 shares of the business’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $69.29, for a total value of $1,818,862.50. Following the completion of the transaction, the chief executive officer owned 166,801 shares of the company’s stock, valued at $11,557,641.29. This represents a 13.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 165,868 shares of company stock valued at $11,121,890. 0.59% of the stock is owned by company insiders.

Docusign Stock Performance

DOCU opened at $77.52 on Friday. The firm’s fifty day moving average is $66.37 and its two-hundred day moving average is $54.57. The firm has a market cap of $14.49 billion, a PE ratio of 44.78, a price-to-earnings-growth ratio of 2.78 and a beta of 0.86. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $77.60.

Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.07. The company had revenue of $875.75 million during the quarter, compared to analyst estimates of $867.22 million. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The firm’s revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.30 EPS. Equities analysts forecast that Docusign Inc. will post 2.14 EPS for the current fiscal year.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

Positive Sentiment: Deeper Salesforce integration supports growth. Embedding DocuSign’s agreement tools directly into Salesforce’s ecosystem may make the platform more useful to sales teams and connect electronic agreements with AI-driven business processes. Why DocuSign Is Up After Deeper AI Integration Into Salesforce’s Agentforce Ecosystem
Positive Sentiment: AI and IAM expansion are improving the investment narrative. Recent coverage highlights DocuSign’s strategy of embedding AI agreement tools across everyday workflows, while analysts point to growing IAM adoption and strong cash flow as supports for the company’s longer-term outlook. Why You Should Hold DOCU Stock
Positive Sentiment: Strong momentum is attracting investor attention. DOCU recently reached a new 52-week high, and the stock has posted substantial gains over the past several months. Zacks also identified it as a heavily watched and strong-momentum stock, increasing near-term trading interest. DocuSign Breaks to a Fresh 52-Week High
Neutral Sentiment: DocuSign participated in a $5.2 billion-valued financing for AI identity and fraud-prevention company Socure. The investment may provide strategic exposure to an adjacent technology market, but its direct financial effect on DocuSign is unclear. Socure Q3 2026 Results
Negative Sentiment: Valuation is a key risk. With DOCU trading near its 52-week high, some coverage argues the shares could already be above fair value. A reported average analyst target of $71 is below the recent trading level, while competition and cloud-migration costs could pressure margins. Zacks Cites $71 Average Target for DocuSign Stock

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DOCU. Weiss Ratings raised Docusign from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Wells Fargo & Company upped their price objective on Docusign from $55.00 to $60.00 and gave the company an “equal weight” rating in a report on Friday, September 4th. Wall Street Zen lowered Docusign from a “strong-buy” rating to a “buy” rating in a research note on Sunday, August 2nd. BTIG Research raised their target price on Docusign from $60.00 to $75.00 and gave the stock a “buy” rating in a report on Wednesday, September 2nd. Finally, Morgan Stanley boosted their target price on Docusign from $69.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, September 4th. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $67.33.

View Our Latest Stock Analysis on Docusign

Docusign Profile

(Free Report)

DocuSign, Inc (NASDAQ:DOCU) provides cloud-based software for electronically signing, managing and automating agreements. Its platform enables individuals and organizations to prepare, send, sign, track and store documents digitally, helping replace paper-based contracting processes.

The company’s offerings include electronic signature tools, contract lifecycle management, identity verification and authentication services, document generation, agreement analytics and related workflow automation capabilities.